65

MedicalNewsToday

• Bevacizumab Reduces Nasopharyngeal Carcinoma Spread - Trial Finds 27 December, 2011, 12:00 am
  According to a new phase 2 trial published Online First in The Lancet Oncology, the combination of the widely used anti-cancer drug bevacizumab with standard chemo-radiation therapy is safe, and could prolong survival in patients with advanced nasopharyngeal carcinoma, without any apparent increased adverse side effects...
• Follicular Lymphoma - Autologos Stem Cell Transplant Does Not Improve Overall Survival 22 December, 2011, 10:00 am
  According to an online study published in the December issue of the Journal of the National Cancer Institute, high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT) for patients with advanced follicular lymphoma (FL) who received no previous treatment, does not improve overall survival compared with conventional-dose chemotherapy alone...
• Acid Reflux 50% More Common Than Ten Years Ago 25 December, 2011, 12:00 am
  A long-term Norwegian study reveals the number of people who experience acid reflux at least once a week has gone up by nearly 50% in the last 10 years, with women appearing to be more susceptible to the condition than men...
• US Cancer Deaths Continue To Fall, ACS Report 5 January, 2012, 4:00 am
  A new report from the American Cancer Society (ACS) shows that rates of cancer deaths in the United States continue the downward trend of the last two decades...
• Thyroid Surgically Removed, But No Cancer Found - Argentine President Cristina Fernández De Kirchner 8 January, 2012, 11:00 am
  Just after Christmas, President Cristina Fernández de Kirchner was told she had thyroid cancer (papillary carcinoma), the thyroid gland was surgically removed on January 4th, laboratory results now show that there were no cancerous cells - she did not have cancer. Experts say this can occur in approximately 2% of cases and was not a diagnosis error...
• Roche's Avastin Receives EU Approval For Ovarian Cancer 25 December, 2011, 12:00 am
  Roche announced today that its product known as Avastin (bevacizumab) has been approved by the European Union for treatment of ovarian cancer. When used in combination with standard chemotherapy (carboplatin and paclitaxel) it will be part of a front-line (first-line following surgery) regime. Hal Barron M.D...
• Vemurafenib Effective For Some Metastatic Melanoma Patients 22 March, 2012, 4:00 pm
  Results from a phase II multi-center clinical trial involving 132 patients with previously treated BRAF V600-mutant metastatic melanoma, indicate that vemurafenib (PLX4032) - an oral BRAF inhibitor - offered a high rate of response in some patients. According to the researchers from the U.S. and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla...
• IBM Watson Computer To Assist Oncologists 23 March, 2012, 3:00 am
  Watson, the IBM computer that gained fame by beating human contestants on the US television game show Jeopardy! in February 2011, is to play a new role in helping oncologists diagnose and treat cancer...
• Researchers Prepare Clinical Trial That Will Use Fat-Enclosed Nanoparticles To Accurately Irradiate Brain Tumors 21 March, 2012, 1:00 am
  For the past 40 years, radiation has been the most effective method for treating deadly brain tumors called glioblastomas. But, although the targeting technology has been refined, beams of radiation still must pass through healthy brain tissue to reach the tumor, and patients can only tolerate small amounts before developing serious side effects...
• New Cancer Test Is Cheap, Accurate And Fast 22 March, 2012, 10:00 am
  This month's issue of the online EMBO Molecular Medicine Journal reports that researchers from the Huntsman Cancer Institute (HCI) at the University of Utah have discovered a rapid, precise and cost-efficient way to identify cancer-causing rearrangements of genetic material, called chromosomal translocations that occur in the tumor cells of many cancers...